Table of Contents
Table 5-73: Shelby
Table 5-75: Starke
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 47 | 494.1 | 247 | 520.4 | 30 | 347.3 | 123 | 275.0 |
| Esophagus | * | # | 5 | 11.0** | * | # | 6 | 13.1** |
| Stomach | * | # | 4 | # | * | # | 3 | # |
| Colon excluding Rectum | 5 | 61.7** | 25 | 55.2 | * | # | 7 | 15.2** |
| Rectum and Rectosigmoid Junction | * | # | 6 | 11.2** | * | # | 0 | # |
| Liver | * | # | 2 | # | * | # | 3 | # |
| Pancreas | * | # | 5 | 10.8** | * | # | 8 | 18.3** |
| Lung and Bronchus | 8 | 82.2** | 47 | 100.0 | 10 | 114.0** | 42 | 89.2 |
| Melanoma of the Skin | * | # | 8 | 15.1** | * | # | 3 | # |
| Prostate | 9 | 90.7** | 50 | 106.6 | * | # | 9 | 23.9** |
| Urinary Bladder | * | # | 22 | 48.8 | * | # | 6 | 16.9** |
| Kidney and Renal Pelvis | * | # | 11 | 24.8** | * | # | 2 | # |
| Brain and Other Nervous System | * | # | 5 | 9.5** | * | # | 3 | # |
| Non-Hodgkin Lymphoma | * | # | 11 | 21.4** | * | # | 8 | 18.1** |
| Myeloma | * | # | 2 | # | * | # | 0 | # |
| Leukemia | * | # | 9 | 19.2** | * | # | 9 | 19.6** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 33 | 288.9 | 199 | 360.0 | 19 | 161.8** | 78 | 137.9 |
| Colon excluding Rectum | * | # | 21 | 37.4 | * | # | 7 | 12.8** |
| Rectum and Rectosigmoid Junction | * | # | 1 | # | * | # | 0 | # |
| Liver | * | # | 0 | # | * | # | 0 | # |
| Pancreas | * | # | 6 | 10.3** | * | # | 5 | 8.5** |
| Lung and Bronchus | * | # | 18 | 33.3** | * | # | 18 | 32.0** |
| Melanoma of the Skin | * | # | 3 | # | * | # | 0 | # |
| Breast | 12 | 106.5** | 66 | 119.5 | * | # | 13 | 23.2** |
| Cervix Uteri | * | # | 5 | 9.8** | * | # | 4 | # |
| Corpus Uteri | * | # | 11 | 19.6** | * | # | 0 | # |
| Ovary | * | # | 3 | # | * | # | 3 | # |
| Urinary Bladder | * | # | 7 | 12.4** | * | # | 0 | # |
| Kidney and Renal Pelvis | * | # | 7 | 12.2** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 3 | # | * | # | 1 | # |
| Non-Hodgkin Lymphoma | * | # | 17 | 31.1** | * | # | 5 | 8.8** |
| Myeloma | * | # | 1 | # | * | # | 0 | # |
| Leukemia | * | # | 7 | 12.3** | * | # | 5 | 9.7** |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, October 2004
Table of Contents
Table 5-73: Shelby
Table 5-75: Starke
